id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_29900
split_0_train_29900
[ { "id": "split_0_train_29900_passage", "type": "progene_text", "text": [ "This effect was completely inhibited in the presence of the pharmacological ERK 1 / 2 mitogen - activated protein kinase ( MAPK ) pathway inhibitor PD98059 ( 30 microM ) or the p38 MAPK inhibitor SB203580 ( 1 microM ) ." ], "offsets": [ [ 0, 219 ] ] } ]
[ { "id": "split_0_train_48209_entity", "type": "progene_text", "text": [ "ERK 1 / 2" ], "offsets": [ [ 76, 85 ] ], "normalized": [] }, { "id": "split_0_train_48210_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase" ], "offsets": [ [ 86, 120 ] ], "normalized": [] }, { "id": "split_0_train_48211_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 123, 127 ] ], "normalized": [] }, { "id": "split_0_train_48212_entity", "type": "progene_text", "text": [ "p38 MAPK" ], "offsets": [ [ 177, 185 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29901
split_0_train_29901
[ { "id": "split_0_train_29901_passage", "type": "progene_text", "text": [ "Basal adhesion of normoxic cells was not affected by pretreatment with PD98059 and SB203580 ." ], "offsets": [ [ 0, 93 ] ] } ]
[]
[]
[]
[]
split_0_train_29902
split_0_train_29902
[ { "id": "split_0_train_29902_passage", "type": "progene_text", "text": [ "Hypoxia induced a time - dependent activation of ERK 1 / 2 and p38 MAPK activation in human VSMCs , which were completely abolished by PD98059 or SB203580 , respectively ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_48213_entity", "type": "progene_text", "text": [ "ERK 1 / 2" ], "offsets": [ [ 49, 58 ] ], "normalized": [] }, { "id": "split_0_train_48214_entity", "type": "progene_text", "text": [ "p38 MAPK" ], "offsets": [ [ 63, 71 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29903
split_0_train_29903
[ { "id": "split_0_train_29903_passage", "type": "progene_text", "text": [ "Since adhesion of VSMCs to fibronectin and collagen I involves beta(1)-integrin receptors , we used a blocking antibody against beta(1)-integrin ( P5D2 ) to examine potential effects of hypoxia on beta(1) - integrins ." ], "offsets": [ [ 0, 218 ] ] } ]
[ { "id": "split_0_train_48215_entity", "type": "progene_text", "text": [ "fibronectin" ], "offsets": [ [ 27, 38 ] ], "normalized": [] }, { "id": "split_0_train_48216_entity", "type": "progene_text", "text": [ "collagen I" ], "offsets": [ [ 43, 53 ] ], "normalized": [] }, { "id": "split_0_train_48217_entity", "type": "progene_text", "text": [ "beta(1)-integrin" ], "offsets": [ [ 63, 79 ] ], "normalized": [] }, { "id": "split_0_train_48218_entity", "type": "progene_text", "text": [ "beta(1)-integrin" ], "offsets": [ [ 128, 144 ] ], "normalized": [] }, { "id": "split_0_train_48219_entity", "type": "progene_text", "text": [ "beta(1) - integrins" ], "offsets": [ [ 197, 216 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29904
split_0_train_29904
[ { "id": "split_0_train_29904_passage", "type": "progene_text", "text": [ "P5D2 significantly reduced VSMC adhesion to fibronectin and collagen I in normoxia and hypoxia in a comparable manner ; however , beta(1)-integrin protein or mRNA levels were not affected by hypoxia ." ], "offsets": [ [ 0, 200 ] ] } ]
[ { "id": "split_0_train_48220_entity", "type": "progene_text", "text": [ "fibronectin" ], "offsets": [ [ 44, 55 ] ], "normalized": [] }, { "id": "split_0_train_48221_entity", "type": "progene_text", "text": [ "collagen I" ], "offsets": [ [ 60, 70 ] ], "normalized": [] }, { "id": "split_0_train_48222_entity", "type": "progene_text", "text": [ "beta(1)-integrin" ], "offsets": [ [ 130, 146 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29905
split_0_train_29905
[ { "id": "split_0_train_29905_passage", "type": "progene_text", "text": [ "As evidenced by flow cytometry , hypoxia induced a activation of beta(1)-integrins by exposing an conformationally sensitive epitope on the beta(1) - subunit ." ], "offsets": [ [ 0, 159 ] ] } ]
[ { "id": "split_0_train_48223_entity", "type": "progene_text", "text": [ "beta(1)-integrins" ], "offsets": [ [ 65, 82 ] ], "normalized": [] }, { "id": "split_0_train_48224_entity", "type": "progene_text", "text": [ "beta(1)" ], "offsets": [ [ 140, 147 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29906
split_0_train_29906
[ { "id": "split_0_train_29906_passage", "type": "progene_text", "text": [ "These results demonstrate that hypoxia enhances adhesion of VSMC on extracellular matrix proteins by activating beta(1)-integrin ." ], "offsets": [ [ 0, 130 ] ] } ]
[ { "id": "split_0_train_48225_entity", "type": "progene_text", "text": [ "beta(1)-integrin" ], "offsets": [ [ 112, 128 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29907
split_0_train_29907
[ { "id": "split_0_train_29907_passage", "type": "progene_text", "text": [ "Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol ." ], "offsets": [ [ 0, 131 ] ] } ]
[ { "id": "split_0_train_48226_entity", "type": "progene_text", "text": [ "ABCG5" ], "offsets": [ [ 18, 23 ] ], "normalized": [] }, { "id": "split_0_train_48227_entity", "type": "progene_text", "text": [ "ABCG8" ], "offsets": [ [ 28, 33 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29908
split_0_train_29908
[ { "id": "split_0_train_29908_passage", "type": "progene_text", "text": [ "Two ATP - binding cassette ( ABC ) transporters , ABCG5 and ABCG8 , have been proposed to limit sterol absorption and to promote biliary sterol excretion in humans ." ], "offsets": [ [ 0, 165 ] ] } ]
[ { "id": "split_0_train_48228_entity", "type": "progene_text", "text": [ "ABCG5" ], "offsets": [ [ 50, 55 ] ], "normalized": [] }, { "id": "split_0_train_48229_entity", "type": "progene_text", "text": [ "ABCG8" ], "offsets": [ [ 60, 65 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29909
split_0_train_29909
[ { "id": "split_0_train_29909_passage", "type": "progene_text", "text": [ "To test this hypothesis , a P1 clone containing the human ABCG5 and ABCG8 genes was used to generate transgenic mice ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_48230_entity", "type": "progene_text", "text": [ "ABCG5" ], "offsets": [ [ 58, 63 ] ], "normalized": [] }, { "id": "split_0_train_48231_entity", "type": "progene_text", "text": [ "ABCG8" ], "offsets": [ [ 68, 73 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29910
split_0_train_29910
[ { "id": "split_0_train_29910_passage", "type": "progene_text", "text": [ "The transgenes were expressed primarily in the liver and small intestine , mirroring the expression pattern of the endogenous genes ." ], "offsets": [ [ 0, 133 ] ] } ]
[]
[]
[]
[]
split_0_train_29911
split_0_train_29911
[ { "id": "split_0_train_29911_passage", "type": "progene_text", "text": [ "Transgene expression only modestly affected plasma and liver cholesterol levels but profoundly altered cholesterol transport ." ], "offsets": [ [ 0, 126 ] ] } ]
[]
[]
[]
[]
split_0_train_29912
split_0_train_29912
[ { "id": "split_0_train_29912_passage", "type": "progene_text", "text": [ "The fractional absorption of dietary cholesterol was reduced by about 50 % , and biliary cholesterol levels were increased more than fivefold ." ], "offsets": [ [ 0, 143 ] ] } ]
[]
[]
[]
[]
split_0_train_29913
split_0_train_29913
[ { "id": "split_0_train_29913_passage", "type": "progene_text", "text": [ "Fecal neutral sterol excretion was increased three - to sixfold and hepatic cholesterol synthesis increased two - to fourfold in the transgenic mice ." ], "offsets": [ [ 0, 150 ] ] } ]
[]
[]
[]
[]
split_0_train_29914
split_0_train_29914
[ { "id": "split_0_train_29914_passage", "type": "progene_text", "text": [ "No significant changes in the pool size , composition , and fecal excretion of bile acids were observed in the transgenic mice ." ], "offsets": [ [ 0, 128 ] ] } ]
[]
[]
[]
[]
split_0_train_29915
split_0_train_29915
[ { "id": "split_0_train_29915_passage", "type": "progene_text", "text": [ "Transgene expression attenuated the increase in hepatic cholesterol content induced by consumption of a high cholesterol diet ." ], "offsets": [ [ 0, 127 ] ] } ]
[]
[]
[]
[]
split_0_train_29916
split_0_train_29916
[ { "id": "split_0_train_29916_passage", "type": "progene_text", "text": [ "These results demonstrate that increased expression of ABCG5 and ABCG8 selectively drives biliary neutral sterol secretion and reduces intestinal cholesterol absorption , leading to a selective increase in neutral sterol excretion and a compensatory increase in cholesterol synthesis ." ], "offsets": [ [ 0, 285 ] ] } ]
[ { "id": "split_0_train_48232_entity", "type": "progene_text", "text": [ "ABCG5" ], "offsets": [ [ 55, 60 ] ], "normalized": [] }, { "id": "split_0_train_48233_entity", "type": "progene_text", "text": [ "ABCG8" ], "offsets": [ [ 65, 70 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29917
split_0_train_29917
[ { "id": "split_0_train_29917_passage", "type": "progene_text", "text": [ "The Escherichia coli metD locus encodes an ABC transporter which includes Abc ( MetN ) , YaeE ( MetI ) , and YaeC ( MetQ ) ." ], "offsets": [ [ 0, 124 ] ] } ]
[ { "id": "split_0_train_48234_entity", "type": "progene_text", "text": [ "metD" ], "offsets": [ [ 21, 25 ] ], "normalized": [] }, { "id": "split_0_train_48235_entity", "type": "progene_text", "text": [ "ABC transporter" ], "offsets": [ [ 43, 58 ] ], "normalized": [] }, { "id": "split_0_train_48236_entity", "type": "progene_text", "text": [ "Abc" ], "offsets": [ [ 74, 77 ] ], "normalized": [] }, { "id": "split_0_train_48237_entity", "type": "progene_text", "text": [ "MetN" ], "offsets": [ [ 80, 84 ] ], "normalized": [] }, { "id": "split_0_train_48238_entity", "type": "progene_text", "text": [ "YaeE" ], "offsets": [ [ 89, 93 ] ], "normalized": [] }, { "id": "split_0_train_48239_entity", "type": "progene_text", "text": [ "MetI" ], "offsets": [ [ 96, 100 ] ], "normalized": [] }, { "id": "split_0_train_48240_entity", "type": "progene_text", "text": [ "YaeC" ], "offsets": [ [ 109, 113 ] ], "normalized": [] }, { "id": "split_0_train_48241_entity", "type": "progene_text", "text": [ "MetQ" ], "offsets": [ [ 116, 120 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29918
split_0_train_29918
[ { "id": "split_0_train_29918_passage", "type": "progene_text", "text": [ "We report that the genes abc , yaeC , and yaeE comprise metD , an Escherichia coli locus encoding a DL-methionine uptake system ." ], "offsets": [ [ 0, 129 ] ] } ]
[ { "id": "split_0_train_48242_entity", "type": "progene_text", "text": [ "abc" ], "offsets": [ [ 25, 28 ] ], "normalized": [] }, { "id": "split_0_train_48243_entity", "type": "progene_text", "text": [ "yaeC" ], "offsets": [ [ 31, 35 ] ], "normalized": [] }, { "id": "split_0_train_48244_entity", "type": "progene_text", "text": [ "yaeE" ], "offsets": [ [ 42, 46 ] ], "normalized": [] }, { "id": "split_0_train_48245_entity", "type": "progene_text", "text": [ "metD" ], "offsets": [ [ 56, 60 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29919
split_0_train_29919
[ { "id": "split_0_train_29919_passage", "type": "progene_text", "text": [ "MetD is an ABC transporter with Abc the ATPase , YaeE the permease , and YaeC the likely substrate binding protein ." ], "offsets": [ [ 0, 116 ] ] } ]
[ { "id": "split_0_train_48246_entity", "type": "progene_text", "text": [ "MetD" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_48247_entity", "type": "progene_text", "text": [ "ABC transporter" ], "offsets": [ [ 11, 26 ] ], "normalized": [] }, { "id": "split_0_train_48248_entity", "type": "progene_text", "text": [ "Abc" ], "offsets": [ [ 32, 35 ] ], "normalized": [] }, { "id": "split_0_train_48249_entity", "type": "progene_text", "text": [ "ATPase" ], "offsets": [ [ 40, 46 ] ], "normalized": [] }, { "id": "split_0_train_48250_entity", "type": "progene_text", "text": [ "YaeE" ], "offsets": [ [ 49, 53 ] ], "normalized": [] }, { "id": "split_0_train_48251_entity", "type": "progene_text", "text": [ "permease" ], "offsets": [ [ 58, 66 ] ], "normalized": [] }, { "id": "split_0_train_48252_entity", "type": "progene_text", "text": [ "YaeC" ], "offsets": [ [ 73, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29920
split_0_train_29920
[ { "id": "split_0_train_29920_passage", "type": "progene_text", "text": [ "Expression of these genes is regulated by L-methionine and MetJ , a common repressor of the methionine regulon ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_48253_entity", "type": "progene_text", "text": [ "MetJ" ], "offsets": [ [ 59, 63 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29921
split_0_train_29921
[ { "id": "split_0_train_29921_passage", "type": "progene_text", "text": [ "We propose to rename abc , yaeE , and yaeC as metN , metI , and metQ , respectively ." ], "offsets": [ [ 0, 85 ] ] } ]
[ { "id": "split_0_train_48254_entity", "type": "progene_text", "text": [ "abc" ], "offsets": [ [ 21, 24 ] ], "normalized": [] }, { "id": "split_0_train_48255_entity", "type": "progene_text", "text": [ "yaeE" ], "offsets": [ [ 27, 31 ] ], "normalized": [] }, { "id": "split_0_train_48256_entity", "type": "progene_text", "text": [ "yaeC" ], "offsets": [ [ 38, 42 ] ], "normalized": [] }, { "id": "split_0_train_48257_entity", "type": "progene_text", "text": [ "metN" ], "offsets": [ [ 46, 50 ] ], "normalized": [] }, { "id": "split_0_train_48258_entity", "type": "progene_text", "text": [ "metI" ], "offsets": [ [ 53, 57 ] ], "normalized": [] }, { "id": "split_0_train_48259_entity", "type": "progene_text", "text": [ "metQ" ], "offsets": [ [ 64, 68 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29922
split_0_train_29922
[ { "id": "split_0_train_29922_passage", "type": "progene_text", "text": [ "Expression of trophinin in the cycling endometrium and its association with infertility ." ], "offsets": [ [ 0, 89 ] ] } ]
[ { "id": "split_0_train_48260_entity", "type": "progene_text", "text": [ "trophinin" ], "offsets": [ [ 14, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29923
split_0_train_29923
[ { "id": "split_0_train_29923_passage", "type": "progene_text", "text": [ "OBJECTIVE :" ], "offsets": [ [ 0, 11 ] ] } ]
[]
[]
[]
[]
split_0_train_29924
split_0_train_29924
[ { "id": "split_0_train_29924_passage", "type": "progene_text", "text": [ "To observe the expression of trophinin in the cycling endometrium and investigate its relationship with infertility ." ], "offsets": [ [ 0, 117 ] ] } ]
[ { "id": "split_0_train_48261_entity", "type": "progene_text", "text": [ "trophinin" ], "offsets": [ [ 29, 38 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29925
split_0_train_29925
[ { "id": "split_0_train_29925_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_29926
split_0_train_29926
[ { "id": "split_0_train_29926_passage", "type": "progene_text", "text": [ "Trophinin expression in the endometrium was observed in 39 normal cycling women during different menstrual phases and 24 women with infertility during mid - luteal phase by immunohistochemical technique ." ], "offsets": [ [ 0, 204 ] ] } ]
[ { "id": "split_0_train_48262_entity", "type": "progene_text", "text": [ "Trophinin" ], "offsets": [ [ 0, 9 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29927
split_0_train_29927
[ { "id": "split_0_train_29927_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_29928
split_0_train_29928
[ { "id": "split_0_train_29928_passage", "type": "progene_text", "text": [ "Trophinin expression was detected in the luteal - phase endometrium of both normal and infertile women , which peaked in the mid - luteal phase ." ], "offsets": [ [ 0, 145 ] ] } ]
[ { "id": "split_0_train_48263_entity", "type": "progene_text", "text": [ "Trophinin" ], "offsets": [ [ 0, 9 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29929
split_0_train_29929
[ { "id": "split_0_train_29929_passage", "type": "progene_text", "text": [ "In comparison with normal women , infertile women with endometriosis or unexplained infertility had significantly weakened trophinin expression in the endometrium in the mid - luteal ( P < 0.001 ) ." ], "offsets": [ [ 0, 198 ] ] } ]
[ { "id": "split_0_train_48264_entity", "type": "progene_text", "text": [ "trophinin" ], "offsets": [ [ 123, 132 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29930
split_0_train_29930
[ { "id": "split_0_train_29930_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]
split_0_train_29931
split_0_train_29931
[ { "id": "split_0_train_29931_passage", "type": "progene_text", "text": [ "Trophinin may play an important role in the process of implantation , and abnormal endometrial trophinin expression might be one of the major causes of infertility ." ], "offsets": [ [ 0, 165 ] ] } ]
[ { "id": "split_0_train_48265_entity", "type": "progene_text", "text": [ "Trophinin" ], "offsets": [ [ 0, 9 ] ], "normalized": [] }, { "id": "split_0_train_48266_entity", "type": "progene_text", "text": [ "trophinin" ], "offsets": [ [ 95, 104 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29932
split_0_train_29932
[ { "id": "split_0_train_29932_passage", "type": "progene_text", "text": [ "Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk ." ], "offsets": [ [ 0, 114 ] ] } ]
[ { "id": "split_0_train_48267_entity", "type": "progene_text", "text": [ "Microsomal epoxide hydrolase" ], "offsets": [ [ 0, 28 ] ], "normalized": [] }, { "id": "split_0_train_48268_entity", "type": "progene_text", "text": [ "glutathione S-transferase" ], "offsets": [ [ 33, 58 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29933
split_0_train_29933
[ { "id": "split_0_train_29933_passage", "type": "progene_text", "text": [ "Two polymorphic sites of the microsomal epoxide hydrolase gene ( EPHX1 , 113Tyr --> 113His , 139His --> 139Arg ) and four glutathione S-transferase genes ( GSTM1 , GSTM3 , GSTP1 , GSTT1 ) were genotyped in a group of patients with larynx cancer ( N = 204 ) and in a group of healthy controls ( N = 203 ) , all Spanish caucasians ." ], "offsets": [ [ 0, 330 ] ] } ]
[ { "id": "split_0_train_48269_entity", "type": "progene_text", "text": [ "microsomal epoxide hydrolase" ], "offsets": [ [ 29, 57 ] ], "normalized": [] }, { "id": "split_0_train_48270_entity", "type": "progene_text", "text": [ "EPHX1" ], "offsets": [ [ 65, 70 ] ], "normalized": [] }, { "id": "split_0_train_48271_entity", "type": "progene_text", "text": [ "glutathione S-transferase" ], "offsets": [ [ 122, 147 ] ], "normalized": [] }, { "id": "split_0_train_48272_entity", "type": "progene_text", "text": [ "GSTM1" ], "offsets": [ [ 156, 161 ] ], "normalized": [] }, { "id": "split_0_train_48273_entity", "type": "progene_text", "text": [ "GSTM3" ], "offsets": [ [ 164, 169 ] ], "normalized": [] }, { "id": "split_0_train_48274_entity", "type": "progene_text", "text": [ "GSTP1" ], "offsets": [ [ 172, 177 ] ], "normalized": [] }, { "id": "split_0_train_48275_entity", "type": "progene_text", "text": [ "GSTT1" ], "offsets": [ [ 180, 185 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29934
split_0_train_29934
[ { "id": "split_0_train_29934_passage", "type": "progene_text", "text": [ "After adjusting for gender , age , and tobacco smoking , none of the polymorphisms alone were found to be associated with larynx cancer risk ." ], "offsets": [ [ 0, 142 ] ] } ]
[]
[]
[]
[]
split_0_train_29935
split_0_train_29935
[ { "id": "split_0_train_29935_passage", "type": "progene_text", "text": [ "The analysis of EPHX1 / GST combinations , however , showed a significant over - representation of patients with a combination of 113Tyr / 113Tyr EPHX1 and 105Ile / 105Ile GSTP1 ( adjusted odds ratio ( OR ) : 1.95 ; 95 % confidence interval ( CI ) : 1.02 - 3.78 ) ." ], "offsets": [ [ 0, 265 ] ] } ]
[ { "id": "split_0_train_48276_entity", "type": "progene_text", "text": [ "EPHX1" ], "offsets": [ [ 16, 21 ] ], "normalized": [] }, { "id": "split_0_train_48277_entity", "type": "progene_text", "text": [ "GST" ], "offsets": [ [ 24, 27 ] ], "normalized": [] }, { "id": "split_0_train_48278_entity", "type": "progene_text", "text": [ "EPHX1" ], "offsets": [ [ 146, 151 ] ], "normalized": [] }, { "id": "split_0_train_48279_entity", "type": "progene_text", "text": [ "GSTP1" ], "offsets": [ [ 172, 177 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29936
split_0_train_29936
[ { "id": "split_0_train_29936_passage", "type": "progene_text", "text": [ "The calculation of the predicted epoxide hydrolase ( EH ) activity also showed an increased risk for the individuals with both predicted high activity EH and 105Ile / 105Ile GSTP1 ( OR : 2.90 ; 95 % CI : 1.10 - 7.67 ) ." ], "offsets": [ [ 0, 219 ] ] } ]
[ { "id": "split_0_train_48280_entity", "type": "progene_text", "text": [ "epoxide hydrolase" ], "offsets": [ [ 33, 50 ] ], "normalized": [] }, { "id": "split_0_train_48281_entity", "type": "progene_text", "text": [ "EH" ], "offsets": [ [ 53, 55 ] ], "normalized": [] }, { "id": "split_0_train_48282_entity", "type": "progene_text", "text": [ "EH" ], "offsets": [ [ 151, 153 ] ], "normalized": [] }, { "id": "split_0_train_48283_entity", "type": "progene_text", "text": [ "GSTP1" ], "offsets": [ [ 174, 179 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29937
split_0_train_29937
[ { "id": "split_0_train_29937_passage", "type": "progene_text", "text": [ "These results on larynx cancer tend to confirm a former study on lung cancer ( Cancer Lett. 173 ( 2001 ) 155 ) suggesting the existence of an interaction between variants of EH and GSTpi , both enzymes being involved in the metabolism of aromatic hydrocarbons , that may increase susceptibility to tobacco - related cancers ." ], "offsets": [ [ 0, 325 ] ] } ]
[ { "id": "split_0_train_48284_entity", "type": "progene_text", "text": [ "EH" ], "offsets": [ [ 174, 176 ] ], "normalized": [] }, { "id": "split_0_train_48285_entity", "type": "progene_text", "text": [ "GSTpi" ], "offsets": [ [ 181, 186 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29938
split_0_train_29938
[ { "id": "split_0_train_29938_passage", "type": "progene_text", "text": [ "Post - translational modification of barley 14-3-3A is isoform - specific and involves removal of the hypervariable C - terminus ." ], "offsets": [ [ 0, 130 ] ] } ]
[ { "id": "split_0_train_48286_entity", "type": "progene_text", "text": [ "14-3-3A" ], "offsets": [ [ 44, 51 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29939
split_0_train_29939
[ { "id": "split_0_train_29939_passage", "type": "progene_text", "text": [ "The 14-3-3 protein family is a family of regulatory proteins involved in diverse cellular processes ." ], "offsets": [ [ 0, 101 ] ] } ]
[ { "id": "split_0_train_48287_entity", "type": "progene_text", "text": [ "14-3-3 protein family" ], "offsets": [ [ 4, 25 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29940
split_0_train_29940
[ { "id": "split_0_train_29940_passage", "type": "progene_text", "text": [ "In a previous study of regulation of individual 14-3-3 isoforms in the germinating barley embryo , we found that a post - translationally modified , 28 kDa form of 14-3-3A was present in specific cell fractions of the germinated embryo ." ], "offsets": [ [ 0, 237 ] ] } ]
[ { "id": "split_0_train_48288_entity", "type": "progene_text", "text": [ "14-3-3" ], "offsets": [ [ 48, 54 ] ], "normalized": [] }, { "id": "split_0_train_48289_entity", "type": "progene_text", "text": [ "14-3-3A" ], "offsets": [ [ 164, 171 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29941
split_0_train_29941
[ { "id": "split_0_train_29941_passage", "type": "progene_text", "text": [ "In the present study , we identify the nature of the modification of 14-3-3A , and show that the 28 kDa doublet is the result of cleavage of the C-terminus ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_48290_entity", "type": "progene_text", "text": [ "14-3-3A" ], "offsets": [ [ 69, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29942
split_0_train_29942
[ { "id": "split_0_train_29942_passage", "type": "progene_text", "text": [ "The 28 kDa forms of 14-3-3A lack ten or twelve amino acid residues at the non - conserved C - terminus of the protein , respectively ." ], "offsets": [ [ 0, 134 ] ] } ]
[ { "id": "split_0_train_48291_entity", "type": "progene_text", "text": [ "14-3-3A" ], "offsets": [ [ 20, 27 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29943
split_0_train_29943
[ { "id": "split_0_train_29943_passage", "type": "progene_text", "text": [ "Barley 14-3-3B and 14-3-3C are not modified in a similar way ." ], "offsets": [ [ 0, 62 ] ] } ]
[ { "id": "split_0_train_48292_entity", "type": "progene_text", "text": [ "14-3-3B" ], "offsets": [ [ 7, 14 ] ], "normalized": [] }, { "id": "split_0_train_48293_entity", "type": "progene_text", "text": [ "14-3-3C" ], "offsets": [ [ 19, 26 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29944
split_0_train_29944
[ { "id": "split_0_train_29944_passage", "type": "progene_text", "text": [ "Like the 30 kDa form , in vitro produced 28 kDa 14-3-3A is still capable of binding AHA2 H+-ATPase in an overlay assay ." ], "offsets": [ [ 0, 120 ] ] } ]
[ { "id": "split_0_train_48294_entity", "type": "progene_text", "text": [ "14-3-3A" ], "offsets": [ [ 48, 55 ] ], "normalized": [] }, { "id": "split_0_train_48295_entity", "type": "progene_text", "text": [ "AHA2 H+-ATPase" ], "offsets": [ [ 84, 98 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29945
split_0_train_29945
[ { "id": "split_0_train_29945_passage", "type": "progene_text", "text": [ "Our results show a novel isoform - specific post - translational modification of 14-3-3 proteins that is regulated in a tissue - specific and developmental way ." ], "offsets": [ [ 0, 161 ] ] } ]
[ { "id": "split_0_train_48296_entity", "type": "progene_text", "text": [ "14-3-3 proteins" ], "offsets": [ [ 81, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29946
split_0_train_29946
[ { "id": "split_0_train_29946_passage", "type": "progene_text", "text": [ "Cdk9 , a member of the cdc2 - like family of kinases , binds to gp130 , the receptor of the IL-6 family of cytokines ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_48297_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_48298_entity", "type": "progene_text", "text": [ "cdc2 - like family of kinases" ], "offsets": [ [ 23, 52 ] ], "normalized": [] }, { "id": "split_0_train_48299_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 64, 69 ] ], "normalized": [] }, { "id": "split_0_train_48300_entity", "type": "progene_text", "text": [ "IL-6 family of cytokines" ], "offsets": [ [ 92, 116 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29947
split_0_train_29947
[ { "id": "split_0_train_29947_passage", "type": "progene_text", "text": [ "Cdk9 is a member of the Cdc2 - like family of kinases ." ], "offsets": [ [ 0, 55 ] ] } ]
[ { "id": "split_0_train_48301_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_48302_entity", "type": "progene_text", "text": [ "Cdc2 - like family of kinases" ], "offsets": [ [ 24, 53 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29948
split_0_train_29948
[ { "id": "split_0_train_29948_passage", "type": "progene_text", "text": [ "It binds to members of the family of cyclin T ( T1 , T2a and T2b ) and to cyclin K ." ], "offsets": [ [ 0, 84 ] ] } ]
[ { "id": "split_0_train_48303_entity", "type": "progene_text", "text": [ "cyclin T ( T1 , T2a and T2b )" ], "offsets": [ [ 37, 66 ] ], "normalized": [] }, { "id": "split_0_train_48304_entity", "type": "progene_text", "text": [ "cyclin K" ], "offsets": [ [ 74, 82 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29949
split_0_train_29949
[ { "id": "split_0_train_29949_passage", "type": "progene_text", "text": [ "The Cdk9 / cyclin T complex appears to be involved in regulating several physiological processes ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_48305_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_48306_entity", "type": "progene_text", "text": [ "cyclin T" ], "offsets": [ [ 11, 19 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29950
split_0_train_29950
[ { "id": "split_0_train_29950_passage", "type": "progene_text", "text": [ "In fact Cdk9 is the kinase of the P-TEFb complex , involved in basal transcription ." ], "offsets": [ [ 0, 84 ] ] } ]
[ { "id": "split_0_train_48307_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 8, 12 ] ], "normalized": [] }, { "id": "split_0_train_48308_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 20, 26 ] ], "normalized": [] }, { "id": "split_0_train_48309_entity", "type": "progene_text", "text": [ "P-TEFb complex" ], "offsets": [ [ 34, 48 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29951
split_0_train_29951
[ { "id": "split_0_train_29951_passage", "type": "progene_text", "text": [ "Cdk9 has also been described as the kinase of the TAK complex , homologous to P-TEFb and involved in HIV replication ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_48310_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_48311_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 36, 42 ] ], "normalized": [] }, { "id": "split_0_train_48312_entity", "type": "progene_text", "text": [ "TAK complex" ], "offsets": [ [ 50, 61 ] ], "normalized": [] }, { "id": "split_0_train_48313_entity", "type": "progene_text", "text": [ "P-TEFb" ], "offsets": [ [ 78, 84 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29952
split_0_train_29952
[ { "id": "split_0_train_29952_passage", "type": "progene_text", "text": [ "Here we show that Cdk9 interacts with gp130 , the receptor of the Interleukin-6 ( IL-6 ) family of cytokines , which includes Leukemia Inhibitory Factor ( LIF ) , Oncostatin M ( OSM ) , Ciliary Neurotrophic Factor ( CNTF ) , Interleukin-11 ( IL-11 ) and Cardiotrophin ( CT-1 ) ." ], "offsets": [ [ 0, 278 ] ] } ]
[ { "id": "split_0_train_48314_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 18, 22 ] ], "normalized": [] }, { "id": "split_0_train_48315_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 38, 43 ] ], "normalized": [] }, { "id": "split_0_train_48316_entity", "type": "progene_text", "text": [ "Interleukin-6 ( IL-6 ) family of cytokines" ], "offsets": [ [ 66, 108 ] ], "normalized": [] }, { "id": "split_0_train_48317_entity", "type": "progene_text", "text": [ "Leukemia Inhibitory Factor" ], "offsets": [ [ 126, 152 ] ], "normalized": [] }, { "id": "split_0_train_48318_entity", "type": "progene_text", "text": [ "LIF" ], "offsets": [ [ 155, 158 ] ], "normalized": [] }, { "id": "split_0_train_48319_entity", "type": "progene_text", "text": [ "Oncostatin M" ], "offsets": [ [ 163, 175 ] ], "normalized": [] }, { "id": "split_0_train_48320_entity", "type": "progene_text", "text": [ "OSM" ], "offsets": [ [ 178, 181 ] ], "normalized": [] }, { "id": "split_0_train_48321_entity", "type": "progene_text", "text": [ "Ciliary Neurotrophic Factor" ], "offsets": [ [ 186, 213 ] ], "normalized": [] }, { "id": "split_0_train_48322_entity", "type": "progene_text", "text": [ "CNTF" ], "offsets": [ [ 216, 220 ] ], "normalized": [] }, { "id": "split_0_train_48323_entity", "type": "progene_text", "text": [ "Interleukin-11" ], "offsets": [ [ 225, 239 ] ], "normalized": [] }, { "id": "split_0_train_48324_entity", "type": "progene_text", "text": [ "IL-11" ], "offsets": [ [ 242, 247 ] ], "normalized": [] }, { "id": "split_0_train_48325_entity", "type": "progene_text", "text": [ "Cardiotrophin" ], "offsets": [ [ 254, 267 ] ], "normalized": [] }, { "id": "split_0_train_48326_entity", "type": "progene_text", "text": [ "CT-1" ], "offsets": [ [ 270, 274 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29953
split_0_train_29953
[ { "id": "split_0_train_29953_passage", "type": "progene_text", "text": [ "IL-6 is a key regulator of hematopoiesis , immunological responses and inflammation ." ], "offsets": [ [ 0, 85 ] ] } ]
[ { "id": "split_0_train_48327_entity", "type": "progene_text", "text": [ "IL-6" ], "offsets": [ [ 0, 4 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29954
split_0_train_29954
[ { "id": "split_0_train_29954_passage", "type": "progene_text", "text": [ "In addition , IL-6 plays a major role in the endocrine and nervous systems ." ], "offsets": [ [ 0, 76 ] ] } ]
[ { "id": "split_0_train_48328_entity", "type": "progene_text", "text": [ "IL-6" ], "offsets": [ [ 14, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29955
split_0_train_29955
[ { "id": "split_0_train_29955_passage", "type": "progene_text", "text": [ "Signal transduction by gp130 is mediated by physical interaction of the cytoplasmic region of gp130 with cellular kinases and results in the transcriptional activation of cellular and viral genes ." ], "offsets": [ [ 0, 197 ] ] } ]
[ { "id": "split_0_train_48329_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 23, 28 ] ], "normalized": [] }, { "id": "split_0_train_48330_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 94, 99 ] ], "normalized": [] }, { "id": "split_0_train_48331_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 114, 121 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29956
split_0_train_29956
[ { "id": "split_0_train_29956_passage", "type": "progene_text", "text": [ "We found that Cdk9 interacts in vitro with the cytoplasmic region of gp130 and we succeded in reproducing this interaction in vivo ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_48332_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 14, 18 ] ], "normalized": [] }, { "id": "split_0_train_48333_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 69, 74 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29957
split_0_train_29957
[ { "id": "split_0_train_29957_passage", "type": "progene_text", "text": [ "Cdk9 expression was found both in the nucleus and in the cytoplasm ." ], "offsets": [ [ 0, 68 ] ] } ]
[ { "id": "split_0_train_48334_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 0, 4 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29958
split_0_train_29958
[ { "id": "split_0_train_29958_passage", "type": "progene_text", "text": [ "The binding occurring between Cdk9 and gp130 increased upon IL-6 stimulation ." ], "offsets": [ [ 0, 78 ] ] } ]
[ { "id": "split_0_train_48335_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 30, 34 ] ], "normalized": [] }, { "id": "split_0_train_48336_entity", "type": "progene_text", "text": [ "gp130" ], "offsets": [ [ 39, 44 ] ], "normalized": [] }, { "id": "split_0_train_48337_entity", "type": "progene_text", "text": [ "IL-6" ], "offsets": [ [ 60, 64 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29959
split_0_train_29959
[ { "id": "split_0_train_29959_passage", "type": "progene_text", "text": [ "We also observed that Cdk9 synergized with IL-6 in inducing the activation of an IL-6 - responsive reporter plasmid ." ], "offsets": [ [ 0, 117 ] ] } ]
[ { "id": "split_0_train_48338_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 22, 26 ] ], "normalized": [] }, { "id": "split_0_train_48339_entity", "type": "progene_text", "text": [ "IL-6" ], "offsets": [ [ 43, 47 ] ], "normalized": [] }, { "id": "split_0_train_48340_entity", "type": "progene_text", "text": [ "IL-6" ], "offsets": [ [ 81, 85 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29960
split_0_train_29960
[ { "id": "split_0_train_29960_passage", "type": "progene_text", "text": [ "In summary , these results point to a previously undisclosed role for Cdk9 in signal transduction ." ], "offsets": [ [ 0, 99 ] ] } ]
[ { "id": "split_0_train_48341_entity", "type": "progene_text", "text": [ "Cdk9" ], "offsets": [ [ 70, 74 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29961
split_0_train_29961
[ { "id": "split_0_train_29961_passage", "type": "progene_text", "text": [ "LIGHT , a member of the tumor necrosis factor ligand superfamily , prevents tumor necrosis factor - alpha - mediated human primary hepatocyte apoptosis , but not Fas - mediated apoptosis ." ], "offsets": [ [ 0, 188 ] ] } ]
[ { "id": "split_0_train_48342_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_48343_entity", "type": "progene_text", "text": [ "tumor necrosis factor ligand superfamily" ], "offsets": [ [ 24, 64 ] ], "normalized": [] }, { "id": "split_0_train_48344_entity", "type": "progene_text", "text": [ "tumor necrosis factor - alpha" ], "offsets": [ [ 76, 105 ] ], "normalized": [] }, { "id": "split_0_train_48345_entity", "type": "progene_text", "text": [ "Fas" ], "offsets": [ [ 162, 165 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29962
split_0_train_29962
[ { "id": "split_0_train_29962_passage", "type": "progene_text", "text": [ "LIGHT is a member of tumor necrosis factor ( TNF ) superfamily , and its receptors have been identified as lymphotoxin-beta receptor ( LTbetaR ) and the herpesvirus entry mediator ( HVEM ) / ATAR / TR2 , both of which lack the cytoplasmic sequence termed the \" death domain. \"" ], "offsets": [ [ 0, 276 ] ] } ]
[ { "id": "split_0_train_48346_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_48347_entity", "type": "progene_text", "text": [ "tumor necrosis factor ( TNF ) superfamily" ], "offsets": [ [ 21, 62 ] ], "normalized": [] }, { "id": "split_0_train_48348_entity", "type": "progene_text", "text": [ "lymphotoxin-beta receptor" ], "offsets": [ [ 107, 132 ] ], "normalized": [] }, { "id": "split_0_train_48349_entity", "type": "progene_text", "text": [ "LTbetaR" ], "offsets": [ [ 135, 142 ] ], "normalized": [] }, { "id": "split_0_train_48350_entity", "type": "progene_text", "text": [ "herpesvirus entry mediator" ], "offsets": [ [ 153, 179 ] ], "normalized": [] }, { "id": "split_0_train_48351_entity", "type": "progene_text", "text": [ "HVEM" ], "offsets": [ [ 182, 186 ] ], "normalized": [] }, { "id": "split_0_train_48352_entity", "type": "progene_text", "text": [ "ATAR" ], "offsets": [ [ 191, 195 ] ], "normalized": [] }, { "id": "split_0_train_48353_entity", "type": "progene_text", "text": [ "TR2" ], "offsets": [ [ 198, 201 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29963
split_0_train_29963
[ { "id": "split_0_train_29963_passage", "type": "progene_text", "text": [ "The present study has demonstrated that LIGHT inhibits TNFalpha - mediated apoptosis of human primary hepatocytes sensitized by actinomycin D ( ActD ) , but not Fas - or TRAIL - mediated apoptosis ." ], "offsets": [ [ 0, 198 ] ] } ]
[ { "id": "split_0_train_48354_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 40, 45 ] ], "normalized": [] }, { "id": "split_0_train_48355_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 55, 63 ] ], "normalized": [] }, { "id": "split_0_train_48356_entity", "type": "progene_text", "text": [ "Fas" ], "offsets": [ [ 161, 164 ] ], "normalized": [] }, { "id": "split_0_train_48357_entity", "type": "progene_text", "text": [ "TRAIL" ], "offsets": [ [ 170, 175 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29964
split_0_train_29964
[ { "id": "split_0_train_29964_passage", "type": "progene_text", "text": [ "Furthermore , LIGHT does not prevent some cell lines such as HepG2 or HeLa from undergoing ActD / TNFalpha - induced apoptosis ." ], "offsets": [ [ 0, 128 ] ] } ]
[ { "id": "split_0_train_48358_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 14, 19 ] ], "normalized": [] }, { "id": "split_0_train_48359_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 98, 106 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29965
split_0_train_29965
[ { "id": "split_0_train_29965_passage", "type": "progene_text", "text": [ "This protective effect requires LIGHT pretreatment at least 3 h prior to ActD sensitization ." ], "offsets": [ [ 0, 93 ] ] } ]
[ { "id": "split_0_train_48360_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 32, 37 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29966
split_0_train_29966
[ { "id": "split_0_train_29966_passage", "type": "progene_text", "text": [ "LIGHT stimulates nuclear factor - kappaB ( NF-kappaB ) - dependent transcriptional activity in human hepatocytes like TNFalpha ." ], "offsets": [ [ 0, 128 ] ] } ]
[ { "id": "split_0_train_48361_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_48362_entity", "type": "progene_text", "text": [ "nuclear factor - kappaB" ], "offsets": [ [ 17, 40 ] ], "normalized": [] }, { "id": "split_0_train_48363_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 43, 52 ] ], "normalized": [] }, { "id": "split_0_train_48364_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 118, 126 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29967
split_0_train_29967
[ { "id": "split_0_train_29967_passage", "type": "progene_text", "text": [ "The time course of NF-kappaB activation after LIGHT administration is similar to that of the pretreatment required for the anti - apoptotic effect of LIGHT ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_48365_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 19, 28 ] ], "normalized": [] }, { "id": "split_0_train_48366_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 46, 51 ] ], "normalized": [] }, { "id": "split_0_train_48367_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 150, 155 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29968
split_0_train_29968
[ { "id": "split_0_train_29968_passage", "type": "progene_text", "text": [ "LIGHT inhibits caspase-3 processing on the apoptotic protease cascade in TNFalpha - mediated apoptosis but not Fas - mediated apoptosis ." ], "offsets": [ [ 0, 137 ] ] } ]
[ { "id": "split_0_train_48368_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_48369_entity", "type": "progene_text", "text": [ "caspase-3" ], "offsets": [ [ 15, 24 ] ], "normalized": [] }, { "id": "split_0_train_48370_entity", "type": "progene_text", "text": [ "protease" ], "offsets": [ [ 53, 61 ] ], "normalized": [] }, { "id": "split_0_train_48371_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 73, 81 ] ], "normalized": [] }, { "id": "split_0_train_48372_entity", "type": "progene_text", "text": [ "Fas" ], "offsets": [ [ 111, 114 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29969
split_0_train_29969
[ { "id": "split_0_train_29969_passage", "type": "progene_text", "text": [ "In addition , increased caspase-3 and caspase-8 activities in ActD / TNFalpha - treated cells are effectively blocked by LIGHT pretreatment ." ], "offsets": [ [ 0, 141 ] ] } ]
[ { "id": "split_0_train_48373_entity", "type": "progene_text", "text": [ "caspase-3" ], "offsets": [ [ 24, 33 ] ], "normalized": [] }, { "id": "split_0_train_48374_entity", "type": "progene_text", "text": [ "caspase-8" ], "offsets": [ [ 38, 47 ] ], "normalized": [] }, { "id": "split_0_train_48375_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 69, 77 ] ], "normalized": [] }, { "id": "split_0_train_48376_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 121, 126 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29970
split_0_train_29970
[ { "id": "split_0_train_29970_passage", "type": "progene_text", "text": [ "However , LIGHT does not change the expression of TNFRp55 , TNFRp75 , and Fas ." ], "offsets": [ [ 0, 79 ] ] } ]
[ { "id": "split_0_train_48377_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 10, 15 ] ], "normalized": [] }, { "id": "split_0_train_48378_entity", "type": "progene_text", "text": [ "TNFRp55" ], "offsets": [ [ 50, 57 ] ], "normalized": [] }, { "id": "split_0_train_48379_entity", "type": "progene_text", "text": [ "TNFRp75" ], "offsets": [ [ 60, 67 ] ], "normalized": [] }, { "id": "split_0_train_48380_entity", "type": "progene_text", "text": [ "Fas" ], "offsets": [ [ 74, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29971
split_0_train_29971
[ { "id": "split_0_train_29971_passage", "type": "progene_text", "text": [ "These results indicate that LIGHT may act as an anti - apoptotic agent against TNFalpha - mediated liver injury by blocking the activation of both caspase-3 and caspase-8 ." ], "offsets": [ [ 0, 172 ] ] } ]
[ { "id": "split_0_train_48381_entity", "type": "progene_text", "text": [ "LIGHT" ], "offsets": [ [ 28, 33 ] ], "normalized": [] }, { "id": "split_0_train_48382_entity", "type": "progene_text", "text": [ "TNFalpha" ], "offsets": [ [ 79, 87 ] ], "normalized": [] }, { "id": "split_0_train_48383_entity", "type": "progene_text", "text": [ "caspase-3" ], "offsets": [ [ 147, 156 ] ], "normalized": [] }, { "id": "split_0_train_48384_entity", "type": "progene_text", "text": [ "caspase-8" ], "offsets": [ [ 161, 170 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29972
split_0_train_29972
[ { "id": "split_0_train_29972_passage", "type": "progene_text", "text": [ "A naturally occurring point substitution in Cdc25A , and not Fv2 / Stk , is associated with altered cell - cycle status of early erythroid progenitor cells ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_48385_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 44, 50 ] ], "normalized": [] }, { "id": "split_0_train_48386_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 61, 64 ] ], "normalized": [] }, { "id": "split_0_train_48387_entity", "type": "progene_text", "text": [ "Stk" ], "offsets": [ [ 67, 70 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29973
split_0_train_29973
[ { "id": "split_0_train_29973_passage", "type": "progene_text", "text": [ "The Friend virus susceptibility gene 2 ( Fv2 ) controls the polyclonal expansion of infected cells that occurs early during Friend erythroleukemia virus infection ." ], "offsets": [ [ 0, 164 ] ] } ]
[ { "id": "split_0_train_48388_entity", "type": "progene_text", "text": [ "Friend virus susceptibility gene 2" ], "offsets": [ [ 4, 38 ] ], "normalized": [] }, { "id": "split_0_train_48389_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 41, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29974
split_0_train_29974
[ { "id": "split_0_train_29974_passage", "type": "progene_text", "text": [ "Fv2 has recently been shown to encode a truncated form of the Stk receptor tyrosine kinase ( Sf-Stk ) ." ], "offsets": [ [ 0, 103 ] ] } ]
[ { "id": "split_0_train_48390_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 0, 3 ] ], "normalized": [] }, { "id": "split_0_train_48391_entity", "type": "progene_text", "text": [ "Stk" ], "offsets": [ [ 62, 65 ] ], "normalized": [] }, { "id": "split_0_train_48392_entity", "type": "progene_text", "text": [ "receptor tyrosine kinase" ], "offsets": [ [ 66, 90 ] ], "normalized": [] }, { "id": "split_0_train_48393_entity", "type": "progene_text", "text": [ "Sf-Stk" ], "offsets": [ [ 93, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29975
split_0_train_29975
[ { "id": "split_0_train_29975_passage", "type": "progene_text", "text": [ "This observation , coupled with earlier work , suggested that Sf-Stk drives the expansion of infected cells by forming a complex with the Friend virus envelope glycoprotein , gp55 , and the erythropoietin receptor ." ], "offsets": [ [ 0, 215 ] ] } ]
[ { "id": "split_0_train_48394_entity", "type": "progene_text", "text": [ "Sf-Stk" ], "offsets": [ [ 62, 68 ] ], "normalized": [] }, { "id": "split_0_train_48395_entity", "type": "progene_text", "text": [ "gp55" ], "offsets": [ [ 175, 179 ] ], "normalized": [] }, { "id": "split_0_train_48396_entity", "type": "progene_text", "text": [ "erythropoietin receptor" ], "offsets": [ [ 190, 213 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29976
split_0_train_29976
[ { "id": "split_0_train_29976_passage", "type": "progene_text", "text": [ "Fv2 has also been implicated in the control of cell cycling in early erythroid progenitors ( erythroid blast - forming units [ BFU-Es]) ." ], "offsets": [ [ 0, 137 ] ] } ]
[ { "id": "split_0_train_48397_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 0, 3 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29977
split_0_train_29977
[ { "id": "split_0_train_29977_passage", "type": "progene_text", "text": [ "Mouse strains that are homozygous for the resistant allele of Fv2 ( Fv2 ( rr ) ) have few actively cycling BFU-Es ." ], "offsets": [ [ 0, 115 ] ] } ]
[ { "id": "split_0_train_48398_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 62, 65 ] ], "normalized": [] }, { "id": "split_0_train_48399_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 68, 71 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29978
split_0_train_29978
[ { "id": "split_0_train_29978_passage", "type": "progene_text", "text": [ "In this report , we demonstrate that the control of BFU-E cycling is encoded by a gene linked to , but distinct from , Fv2 , and suggest that this gene is the dual - specific protein phosphatase Cdc25A , which regulates the G1 - to S-phase transition of the cell cycle ." ], "offsets": [ [ 0, 270 ] ] } ]
[ { "id": "split_0_train_48400_entity", "type": "progene_text", "text": [ "Fv2" ], "offsets": [ [ 119, 122 ] ], "normalized": [] }, { "id": "split_0_train_48401_entity", "type": "progene_text", "text": [ "dual - specific protein phosphatase" ], "offsets": [ [ 159, 194 ] ], "normalized": [] }, { "id": "split_0_train_48402_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 195, 201 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29979
split_0_train_29979
[ { "id": "split_0_train_29979_passage", "type": "progene_text", "text": [ "We show that a naturally occurring allele of Cdc25A , which increases Cdc25A phosphatase activity and promotes cell - cycle progression , segregates in mouse strains that exhibit high levels of BFU-E cell cycling ." ], "offsets": [ [ 0, 214 ] ] } ]
[ { "id": "split_0_train_48403_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 45, 51 ] ], "normalized": [] }, { "id": "split_0_train_48404_entity", "type": "progene_text", "text": [ "Cdc25A phosphatase" ], "offsets": [ [ 70, 88 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29980
split_0_train_29980
[ { "id": "split_0_train_29980_passage", "type": "progene_text", "text": [ "In wild - type mice , this allele of Cdc25A does not overtly affect erythropoiesis ; however , when this allele is combined with a mutation of the Kit receptor ( Kit ( WV ) ) , the anemia of the mice is enhanced ." ], "offsets": [ [ 0, 213 ] ] } ]
[ { "id": "split_0_train_48405_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 37, 43 ] ], "normalized": [] }, { "id": "split_0_train_48406_entity", "type": "progene_text", "text": [ "Kit" ], "offsets": [ [ 147, 150 ] ], "normalized": [] }, { "id": "split_0_train_48407_entity", "type": "progene_text", "text": [ "Kit" ], "offsets": [ [ 162, 165 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29981
split_0_train_29981
[ { "id": "split_0_train_29981_passage", "type": "progene_text", "text": [ "Furthermore , overexpression of Cdc25A in bone marrow cells causes a defect in the BFU-E colony formation ." ], "offsets": [ [ 0, 107 ] ] } ]
[ { "id": "split_0_train_48408_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 32, 38 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29982
split_0_train_29982
[ { "id": "split_0_train_29982_passage", "type": "progene_text", "text": [ "These results suggest that proper regulation of the cell cycle through Cdc25A is required for normal erythropoiesis ." ], "offsets": [ [ 0, 117 ] ] } ]
[ { "id": "split_0_train_48409_entity", "type": "progene_text", "text": [ "Cdc25A" ], "offsets": [ [ 71, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29983
split_0_train_29983
[ { "id": "split_0_train_29983_passage", "type": "progene_text", "text": [ "IL-4 , but not IL-13 , modulates TARC ( thymus and activation - regulated chemokine ) / CCL17 and IP-10 ( interferon - induced protein of 10kDA ) / CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line ." ], "offsets": [ [ 0, 210 ] ] } ]
[ { "id": "split_0_train_48410_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_48411_entity", "type": "progene_text", "text": [ "IL-13" ], "offsets": [ [ 15, 20 ] ], "normalized": [] }, { "id": "split_0_train_48412_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 33, 37 ] ], "normalized": [] }, { "id": "split_0_train_48413_entity", "type": "progene_text", "text": [ "thymus and activation - regulated chemokine" ], "offsets": [ [ 40, 83 ] ], "normalized": [] }, { "id": "split_0_train_48414_entity", "type": "progene_text", "text": [ "CCL17" ], "offsets": [ [ 88, 93 ] ], "normalized": [] }, { "id": "split_0_train_48415_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 98, 103 ] ], "normalized": [] }, { "id": "split_0_train_48416_entity", "type": "progene_text", "text": [ "interferon - induced protein of 10kDA" ], "offsets": [ [ 106, 143 ] ], "normalized": [] }, { "id": "split_0_train_48417_entity", "type": "progene_text", "text": [ "CXCL10" ], "offsets": [ [ 148, 154 ] ], "normalized": [] }, { "id": "split_0_train_48418_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 166, 175 ] ], "normalized": [] }, { "id": "split_0_train_48419_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 180, 189 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29984
split_0_train_29984
[ { "id": "split_0_train_29984_passage", "type": "progene_text", "text": [ "It is known that both interleukin-4 ( IL-4 ) and IL-13 are produced by Th2 - type cells and share similar biological functions with each other ." ], "offsets": [ [ 0, 144 ] ] } ]
[ { "id": "split_0_train_48420_entity", "type": "progene_text", "text": [ "interleukin-4" ], "offsets": [ [ 22, 35 ] ], "normalized": [] }, { "id": "split_0_train_48421_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 38, 42 ] ], "normalized": [] }, { "id": "split_0_train_48422_entity", "type": "progene_text", "text": [ "IL-13" ], "offsets": [ [ 49, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29985
split_0_train_29985
[ { "id": "split_0_train_29985_passage", "type": "progene_text", "text": [ "However , recently accumulated evidences have revealed that IL-4 may be involved in the Th1 - type response ." ], "offsets": [ [ 0, 109 ] ] } ]
[ { "id": "split_0_train_48423_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 60, 64 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29986
split_0_train_29986
[ { "id": "split_0_train_29986_passage", "type": "progene_text", "text": [ "Both thymus and activation - regulated chemokine ( TARC / CCL17 ) , a ligand for CC chemokine receptor 4 that is mainly expressed on Th2 - type cells , and interferon - induced protein of 10kDa ( IP-10 / CXCL10 ) , a ligand for CXC chemokine receptor 3 that is mainly expressed on Th1 - type cells , are produced by keratinocytes after the stimulation with the primary cytokines such as tumor necrotic factor - alpha ( TNF-alpha ) and/or interferon-gamma ( IFN-gamma ) ." ], "offsets": [ [ 0, 470 ] ] } ]
[ { "id": "split_0_train_48424_entity", "type": "progene_text", "text": [ "thymus and activation - regulated chemokine" ], "offsets": [ [ 5, 48 ] ], "normalized": [] }, { "id": "split_0_train_48425_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 51, 55 ] ], "normalized": [] }, { "id": "split_0_train_48426_entity", "type": "progene_text", "text": [ "CCL17" ], "offsets": [ [ 58, 63 ] ], "normalized": [] }, { "id": "split_0_train_48427_entity", "type": "progene_text", "text": [ "CC chemokine receptor 4" ], "offsets": [ [ 81, 104 ] ], "normalized": [] }, { "id": "split_0_train_48428_entity", "type": "progene_text", "text": [ "interferon - induced protein of 10kDa" ], "offsets": [ [ 156, 193 ] ], "normalized": [] }, { "id": "split_0_train_48429_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 196, 201 ] ], "normalized": [] }, { "id": "split_0_train_48430_entity", "type": "progene_text", "text": [ "CXCL10" ], "offsets": [ [ 204, 210 ] ], "normalized": [] }, { "id": "split_0_train_48431_entity", "type": "progene_text", "text": [ "CXC chemokine receptor 3" ], "offsets": [ [ 228, 252 ] ], "normalized": [] }, { "id": "split_0_train_48432_entity", "type": "progene_text", "text": [ "cytokines" ], "offsets": [ [ 369, 378 ] ], "normalized": [] }, { "id": "split_0_train_48433_entity", "type": "progene_text", "text": [ "tumor necrotic factor - alpha" ], "offsets": [ [ 387, 416 ] ], "normalized": [] }, { "id": "split_0_train_48434_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 419, 428 ] ], "normalized": [] }, { "id": "split_0_train_48435_entity", "type": "progene_text", "text": [ "interferon-gamma" ], "offsets": [ [ 438, 454 ] ], "normalized": [] }, { "id": "split_0_train_48436_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 457, 466 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29987
split_0_train_29987
[ { "id": "split_0_train_29987_passage", "type": "progene_text", "text": [ "In this study , we investigated the regulation of TARC or IP-10 production from HaCaT cells , an immortalized human keratinocyte cell line , after stimulation with TNF-alpha , IFN-gamma , IL-4 and/or IL-13 ." ], "offsets": [ [ 0, 207 ] ] } ]
[ { "id": "split_0_train_48437_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 50, 54 ] ], "normalized": [] }, { "id": "split_0_train_48438_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 58, 63 ] ], "normalized": [] }, { "id": "split_0_train_48439_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 164, 173 ] ], "normalized": [] }, { "id": "split_0_train_48440_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 176, 185 ] ], "normalized": [] }, { "id": "split_0_train_48441_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 188, 192 ] ], "normalized": [] }, { "id": "split_0_train_48442_entity", "type": "progene_text", "text": [ "IL-13" ], "offsets": [ [ 200, 205 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29988
split_0_train_29988
[ { "id": "split_0_train_29988_passage", "type": "progene_text", "text": [ "Without stimulation , HaCaT cells did not produce TARC ." ], "offsets": [ [ 0, 56 ] ] } ]
[ { "id": "split_0_train_48443_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 50, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29989
split_0_train_29989
[ { "id": "split_0_train_29989_passage", "type": "progene_text", "text": [ "When both TNF-alpha and IFN-gamma were added , they increased synergistically ( P < 0.003 ) ." ], "offsets": [ [ 0, 93 ] ] } ]
[ { "id": "split_0_train_48444_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 10, 19 ] ], "normalized": [] }, { "id": "split_0_train_48445_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 24, 33 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29990
split_0_train_29990
[ { "id": "split_0_train_29990_passage", "type": "progene_text", "text": [ "In addition , when HaCaT cells were stimulated with IL-4 , but not IL-13 , in combination with TNF-alpha and IFN-gamma , the supernatant TARC levels significantly decreased compared to those with both TNF-alpha and IFN-gamma ( P < 0.009 ) ." ], "offsets": [ [ 0, 240 ] ] } ]
[ { "id": "split_0_train_48446_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 52, 56 ] ], "normalized": [] }, { "id": "split_0_train_48447_entity", "type": "progene_text", "text": [ "IL-13" ], "offsets": [ [ 67, 72 ] ], "normalized": [] }, { "id": "split_0_train_48448_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 95, 104 ] ], "normalized": [] }, { "id": "split_0_train_48449_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 109, 118 ] ], "normalized": [] }, { "id": "split_0_train_48450_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 137, 141 ] ], "normalized": [] }, { "id": "split_0_train_48451_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 201, 210 ] ], "normalized": [] }, { "id": "split_0_train_48452_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 215, 224 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29991
split_0_train_29991
[ { "id": "split_0_train_29991_passage", "type": "progene_text", "text": [ "This inhibition was completely abolished with the addition of neutralizing anti - IL-4 antibody ." ], "offsets": [ [ 0, 97 ] ] } ]
[ { "id": "split_0_train_48453_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 82, 86 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29992
split_0_train_29992
[ { "id": "split_0_train_29992_passage", "type": "progene_text", "text": [ "The supernatant IP-10 levels also increased synergistically by stimulation with TNF-alpha and IFN-gamma for 24h ( P < 0.001 ) ." ], "offsets": [ [ 0, 127 ] ] } ]
[ { "id": "split_0_train_48454_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 16, 21 ] ], "normalized": [] }, { "id": "split_0_train_48455_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 80, 89 ] ], "normalized": [] }, { "id": "split_0_train_48456_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 94, 103 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29993
split_0_train_29993
[ { "id": "split_0_train_29993_passage", "type": "progene_text", "text": [ "When IL-4 , but not IL-13 , was added to the medium and the cells were co - cultured with these cytokines , the IP-10 levels significantly increased compared to those with both TNF-alpha and IFN-gamma ( P < 0.04 ) ." ], "offsets": [ [ 0, 215 ] ] } ]
[ { "id": "split_0_train_48457_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 5, 9 ] ], "normalized": [] }, { "id": "split_0_train_48458_entity", "type": "progene_text", "text": [ "IL-13" ], "offsets": [ [ 20, 25 ] ], "normalized": [] }, { "id": "split_0_train_48459_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 112, 117 ] ], "normalized": [] }, { "id": "split_0_train_48460_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 177, 186 ] ], "normalized": [] }, { "id": "split_0_train_48461_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 191, 200 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29994
split_0_train_29994
[ { "id": "split_0_train_29994_passage", "type": "progene_text", "text": [ "Furthermore , the effects of IL-4 on TARC and IP-10 production in these cells were detected in a dose - dependent manner ." ], "offsets": [ [ 0, 122 ] ] } ]
[ { "id": "split_0_train_48462_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 29, 33 ] ], "normalized": [] }, { "id": "split_0_train_48463_entity", "type": "progene_text", "text": [ "TARC" ], "offsets": [ [ 37, 41 ] ], "normalized": [] }, { "id": "split_0_train_48464_entity", "type": "progene_text", "text": [ "IP-10" ], "offsets": [ [ 46, 51 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29995
split_0_train_29995
[ { "id": "split_0_train_29995_passage", "type": "progene_text", "text": [ "These data strongly suggest that IL-4 may act not only as a mediator of Th1 - type response but also as a down - regulator of Th2 - type response in terms of the regulation of chemokine production by HaCaT cells ." ], "offsets": [ [ 0, 213 ] ] } ]
[ { "id": "split_0_train_48465_entity", "type": "progene_text", "text": [ "IL-4" ], "offsets": [ [ 33, 37 ] ], "normalized": [] }, { "id": "split_0_train_48466_entity", "type": "progene_text", "text": [ "chemokine" ], "offsets": [ [ 176, 185 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29996
split_0_train_29996
[ { "id": "split_0_train_29996_passage", "type": "progene_text", "text": [ "Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri ." ], "offsets": [ [ 0, 116 ] ] } ]
[]
[]
[]
[]
split_0_train_29997
split_0_train_29997
[ { "id": "split_0_train_29997_passage", "type": "progene_text", "text": [ "We have identified and sequenced the genes encoding the aggregation - promoting factor ( APF ) protein from six different strains of Lactobacillus johnsonii and Lactobacillus gasseri ." ], "offsets": [ [ 0, 184 ] ] } ]
[ { "id": "split_0_train_48467_entity", "type": "progene_text", "text": [ "aggregation - promoting factor" ], "offsets": [ [ 56, 86 ] ], "normalized": [] }, { "id": "split_0_train_48468_entity", "type": "progene_text", "text": [ "APF" ], "offsets": [ [ 89, 92 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29998
split_0_train_29998
[ { "id": "split_0_train_29998_passage", "type": "progene_text", "text": [ "Both species harbor two apf genes , apf1 and apf2 , which are in the same orientation and encode proteins of 257 to 326 amino acids ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_48469_entity", "type": "progene_text", "text": [ "apf" ], "offsets": [ [ 24, 27 ] ], "normalized": [] }, { "id": "split_0_train_48470_entity", "type": "progene_text", "text": [ "apf1" ], "offsets": [ [ 36, 40 ] ], "normalized": [] }, { "id": "split_0_train_48471_entity", "type": "progene_text", "text": [ "apf2" ], "offsets": [ [ 45, 49 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29999
split_0_train_29999
[ { "id": "split_0_train_29999_passage", "type": "progene_text", "text": [ "Multiple alignments of the deduced amino acid sequences of these apf genes demonstrate a very strong sequence conservation of all of the genes with the exception of their central regions ." ], "offsets": [ [ 0, 188 ] ] } ]
[ { "id": "split_0_train_48472_entity", "type": "progene_text", "text": [ "apf" ], "offsets": [ [ 65, 68 ] ], "normalized": [] } ]
[]
[]
[]